News und Analysen
QIAGEN gibt Veröffentlichung der begründeten Stellungnahme zum Übernahmeangebot von Thermo Fisher sowie Datum der Jahreshauptversammlung bekannt
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Veröffentlichung der begründeten Stellungnahme in Reaktion auf die von Thermo Fisher Scientific Inc (NYSE: TMO) früher am
VFMCRP and ChemoCentryx announce topline data from phase-II LUMINA-1 trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200517005052/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Xencor to Present Data from Four Preclinical XmAb® 2+1 Bispecific Antibody and Cytokine Programs at AACR Virtual Annual Meeting II
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced it will
Acadia Healthcare to Participate in the UBS Virtual Global Healthcare Conference and the RBC Capital Markets Global Healthcare Virtual Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two upcoming virtual healthcare conferences.
On Tuesday, May 19, 2020, the Company will present
92. Generalversammlung der Vifor Pharma Gruppe
Regulatory News:
An der 92. ordentlichen Generalversammlung der Vifor Pharma AG haben die Aktionäre alle Beschlussanträge des Verwaltungsrats genehmigt.
Aufgrund der aktuellen Situation und im
92nd Vifor Pharma Group Annual General Meeting
Regulatory News:
At the 92nd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors.
In view of the current situation
Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®20717, PD-1 x CTLA-4 Bispecific Antibody, in Solid Tumors
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported initial
Premier Inc. Survey: Clinically Integrated Networks in Alternative Payment Models Expanded Value-Based Care Capabilities to Manage COVID-19 Surge
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that participants in alternative payment models (APMs) have drawn heavily on their
China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform therapy called Tumor Treating Fields, and Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage
Xencor to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that Bassil
ICON plc to Present at UBS Virtual Global Healthcare Conference
ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr
Molina Healthcare of Ohio Commits $1.5 Million to Advance the Health of Ohioans Through its 2020 Community Innovation Fund
Molina Healthcare of Ohio (“Molina”) is dedicated to building healthier communities and is committing over $1.5 million to support innovative programs across Ohio.
The Molina Community Innovation
LivaNova to Present at the UBS Virtual Global Healthcare Conference
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will present at the UBS Virtual Global Healthcare Conference on
Acadia Healthcare to Participate in BofA Securities 2020 Health Care Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the BofA Securities 2020 Health Care Conference, which takes place May 12 – 14, 2020. This
Premier Inc. Predictive Technology Helps Prepare for Resumption of Elective Procedures by Identifying Surges in COVID-19 Cases and Supply Needs
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is leveraging its technology solutions to help hospitals and health systems across the country anticipate surges in COVID-19
Xencor Reports First Quarter 2020 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported financial
Premier Inc. Survey: Hospitals’ COVID-19 Testing Capacity Must at Least Triple Before Elective Surgeries Can Fully Resume
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released new survey results finding that healthcare facilities need to expand their current COVID-19 testing capacity by
Charles River Laboratories Announces First-Quarter 2020 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2020. For the quarter, revenue was $707.1 million, an increase of 17.0% from $604.6
QIAGEN meldet vollständige Ergebnisse für das erste Quartal 2020
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) gab heute die vollständigen Ergebnisse der operativen Tätigkeit für das erste Quartal 2020 bekannt, wobei der Konzernumsatz und der bereinigte
QIAGEN Reports Full Results for First Quarter of 2020
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) announced full results of operations for the first quarter of 2020, with net sales and adjusted earnings per share (EPS) in line with the
Premier Inc. Puts Unmatched Insights at Clinicians’ Fingertips with Launch of Perinatal Quality Dashboard
Premier Inc. (NASDAQ: PINC) is advancing care for mothers and infants with the launch of its Perinatal Quality Dashboard that delivers self-service, actionable insights to support clinicians on the
QIAGEN Expects Higher Results for Q2 2020 Based on Trends to Date and Suspends Outlook for Full-Year 2020
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) announces that, based on trends to date, it currently expects net sales growth of at least 12% at constant exchange rates (CER) and adjusted
QIAGEN erwartet höheres Ergebnis für das zweite Quartal 2020 auf der Grundlage der bisherigen Trends und setzt den Ausblick für das Gesamtjahr 2020 aus
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) gibt bekannt, dass das Unternehmen derzeit auf der Grundlage der bisherigen Trends für das zweite Quartal 2020 ein Nettoumsatzwachstum von
Chemed Corporation to Present at the BofA Securities 2020 Virtual Health Care Conference
Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2020 Virtual Health Care Conference on Tuesday, May 12, 2020, at 3:00 PM (ET).
The presentation will be
Premier Inc. Reports Fiscal 2020 Third-Quarter Results
Premier Inc. (NASDAQ: PINC) today reported financial results for the fiscal 2020 third quarter ended March 31, 2020.
All results presented in this press release reflect continuing operations